Index Entries

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults by AstraZeneca

https://clinicaltrials.gov/study/NCT04516746?titles=Phase%20III%20Double-blind,%20Placebo-controlled%20Study%20of%20AZD1222%20for%20the%20Prevention%20of%20COVID-19%20in%20Adults&rank=1

updated April 7, 2023
National Library of Medicine
AstraZeneca

“Estimated Actual Completion Date: February 10, 2023”

document
COVID-19,FDA approvals,manufacturers,clinical trials,vaccines